Literature DB >> 21784555

High endemic levels of multidrug-resistant Acinetobacter baumannii among hospitals in southern Brazil.

Andreza F Martins1, Ricardo S Kuchenbecker, Kátia O Pilger, Mariana Pagano, Afonso L Barth.   

Abstract

BACKGROUND: Most published data on multidrug-resistant Acinetobacter baumanii (MDR Ab) are derived from outbreaks. We report incidence trends on health care-acquired infections due to MDR Ab over a 12-month period in the city of Porto Alegre in southern Brazil.
METHODS: Clinical and epidemiologic data were obtained from the local health care information system of the municipal health department. Polymerase chain reaction was used to detect the presence of the genes bla(OXA-23-like), bla(OXA-24-like), bla(OXA-51), and bla(OXA-58), and repetitive sequence-based polymerase chain reaction and pulsed-field gel electrophoresis were performed for molecular typing.
RESULTS: The highest rate of infection (9.0/1,000 inpatient-days) was identified in a trauma hospital. The gene bla(OXA-23-like) was identified in 99.0% of MDR Ab isolates. Eight main clonal groups were identified by molecular typing, and 3 of these were found in all hospitals.
CONCLUSION: The presence of 3 clones in all hospitals demonstrates the ability of MDR Ab to spread among hospitals. Moreover, the occurrence of one particular clone (clone 4) throughout the study period suggests its increased ability to cause outbreaks and to remain in the environment. The monitoring of epidemic strains by molecular methods is of paramount importance to prevent or reduce the spread of MDR Ab. Copyright Â
© 2012 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21784555     DOI: 10.1016/j.ajic.2011.03.010

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  10 in total

Review 1.  Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.

Authors:  Darren Wong; Travis B Nielsen; Robert A Bonomo; Paul Pantapalangkoor; Brian Luna; Brad Spellberg
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

2.  First report of NDM-1-producing Acinetobacter baumannii sequence type 25 in Brazil.

Authors:  Marcelo Pillonetto; Lavinia Arend; Eliana Carolina Vespero; Marsileni Pelisson; Thiago Pavoni Gomes Chagas; Ana Paula D'Alincourt Carvalho-Assef; Marise Dutra Asensi
Journal:  Antimicrob Agents Chemother       Date:  2014-10-06       Impact factor: 5.191

3.  PCR Assay Based on the gyrB Gene for Rapid Identification of Acinetobacter baumannii-calcoaceticus Complex at Specie Level.

Authors:  Aline B Teixeira; Juliana Barin; Djuli M Hermes; Afonso L Barth; Andreza F Martins
Journal:  J Clin Lab Anal       Date:  2016-09-08       Impact factor: 2.352

4.  Arenaviruses and West Nile Virus in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.

Authors:  Judith A Anesi; Fernanda P Silveira
Journal:  Clin Transplant       Date:  2019-05-23       Impact factor: 2.863

Review 5.  Antimicrobial resistance in Acinetobacter baumannii: From bench to bedside.

Authors:  Ming-Feng Lin; Chung-Yu Lan
Journal:  World J Clin Cases       Date:  2014-12-16       Impact factor: 1.337

6.  Carbapenem-susceptible Acinetobacter baumannii carrying the ISAba1 upstream blaOXA-51-like gene in Porto Alegre, southern Brazil.

Authors:  M Pagano; A F Martins; A B M P Machado; J Barin; A L Barth
Journal:  Epidemiol Infect       Date:  2012-04-19       Impact factor: 4.434

7.  A Variant Carbapenem Inactivation Method (CIM) for Acinetobacter baumannii Group with Shortened Time-to-Result: rCIM-A.

Authors:  Dieter Mitteregger; Julian Wessely; Ivan Barišić; Branka Bedenić; Dieter Kosak; Michael Kundi
Journal:  Pathogens       Date:  2022-04-18

8.  Facial ulcerations due to Acinetobacter baumannii: Vessel thrombosis with bacterial mycelia.

Authors:  Dong Ming Li; Ting Ting Sun
Journal:  IDCases       Date:  2014-10-25

9.  Active surveillance of carbapenem-resistant Gram-negative healthcare-associated infections in a low-middle-income country city.

Authors:  Viviane Maria de Carvalho Hessel Dias; Daniela Maria Waszak da Silva; Marion Burger; Alcides Augusto Souto de Oliveira; Patrícia de Jesus Capelo; Fabio Augusto da Rocha Specian; Marianna Cavina de Figueiredo; Felipe Francisco Tuon; Cristina Pellegrino Baena
Journal:  Braz J Infect Dis       Date:  2021-02-13       Impact factor: 3.257

10.  In vitro activity of non-bactericidal concentrations of polymyxin B in combination with other antimicrobials against OXA-23-producing carbapenem-resistant Acinetobacter baumannii.

Authors:  Bárbara Netto; Bruno J Vieira; Djuli M Hermes; Vanessa B Ribeiro; Alexandre P Zavascki
Journal:  Braz J Infect Dis       Date:  2013-06-25       Impact factor: 3.257

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.